← Baker Tilly
Episodes featuring Baker Tilly
191 episodes, newest first.
- Jul 13, 2026
Chipmakers diverge on AI spending as rising oil boosts energy giantsStock MoversJul 13, 2026 - Jul 13, 2026European stocks react to deals, mine cuts and hiring demandStock MoversJul 13, 2026
- Jul 13, 2026AkzoNobel rejects Nippon Paint as chip stocks slideStock MoversJul 13, 2026
- Jul 13, 2026AI demand lifts TSMC as chip and China bets divergeStock MoversJul 13, 2026
- Jul 12, 2026Wall Street braces for pivotal earnings from banking, aviation, and tech giantsStock MoversJul 12, 2026
- Jul 10, 2026WD-40 surges on earnings while tech stocks face downgrades and profit-takingStock MoversJul 10, 2026
- Jul 10, 2026Meta jumps and Forte Biosciences surges while Paramount Skydance slides on debtStock MoversJul 10, 2026
- Jul 10, 2026AI infrastructure spending drives market gains and corporate credit downgradesStock MoversJul 10, 2026
- Jul 10, 2026Meta stock climbs and Delta defies record fuel costs on strong demandStock MoversJul 10, 2026
- Jul 10, 2026Meta and Delta rally while Aritzia delivers massive earnings beatStock MoversJul 10, 2026
- Jul 10, 2026Delta defies high fuel costs as private equity targets EasyJetStock MoversJul 10, 2026
- Jul 10, 2026Aviation and telecom stocks surge on buyout bids and billionaire investmentsStock MoversJul 10, 2026
- Jul 10, 2026EasyJet bidding war reshapes Europe’s market moversStock MoversJul 10, 2026
- Jul 10, 2026Apollo challenges Castlelake in surprise EasyJet bidStock MoversJul 10, 2026
- Jul 10, 2026SK Hynix sets a record as Asian chip optimism spreadsStock MoversJul 10, 2026
- Jul 9, 2026Consumer giants stumble as Starbucks rewrites its AI strategyStock MoversJul 9, 2026
- Jul 9, 2026AI infrastructure lifts Meta as consumer pressure hits PepsiCoStock MoversJul 9, 2026
- Jul 9, 2026AI investment lifts Micron as consumer spending pressures retailersStock MoversJul 9, 2026
- Jul 9, 2026Micron bets big on US chips as consumer demand weakensStock MoversJul 9, 2026
- Jul 9, 2026Micron bets big on US chipmaking as drug trial rattles AstraZenecaStock MoversJul 9, 2026
- Jul 9, 2026Consumer brands expose the pressure on household budgetsStock MoversJul 9, 2026
- Jul 9, 2026Drug trial failure jolts AstraZeneca as mixed earnings reshape market betsStock MoversJul 9, 2026
- Jul 9, 2026European stocks split as drug, pharma and defense names divergeStock MoversJul 9, 2026
- Jul 9, 2026Deutz bets on defense as AstraZeneca trial disappointsStock MoversJul 9, 2026